Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Valeo Pharma Inc VPHIF

Healthcare
Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler, Atectura Breezhaler and Allerject. The ophthalmology products include Xiidra and Simbrinza. Its specialty products include Redesca, Onstryv, M-Eslon, Yondelis and Ametop Gel 4%. The Company's wholly owned subsidiary is VPI Pharmaceuticals Inc.


GREY:VPHIF - Post by User

Valeo Pharma Inc > On track and looking good - added more yesterday
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(51)
•••
Comment by kooter33on May 08, 2021 12:23pm
149 Views
Post# 33159894

RE:RE:RE: On track and looking good - added more yesterday

RE:RE:RE: On track and looking good - added more yesterday
LaurinDE wrote: low trading volume is an invitation to "play" with the stock. As soon as the company releases data that confirms the revenues they promise, there will be serious buying interest and then the share will appreciate very quickly, imo.
L

I am banking on it.  Fully loaded.  this stagflation is mind boggling considering the share float.  Insiders own 65% and don't seem to be interested in moving the share price.  I suspect if we get good solid revenues in Q2-21 ( by the end of June) then we will see a substantial rise in SP.  I hope they don't wait too long as the markets are getting long in the tooth and a correction is inevitable at some point.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities